TD BUY $MNOV at 9.11, Supp 9.10 Resis 11.65 R28 HiLo 36% T1Y 20 strong_buy 1.5 fwdPE -11.7 DIV N/A #MediciNova #stocks #trading #finance #market

2019-06-13
67 Views

TD BUY detected for MNOV (MediciNova, Inc.) at the close price of 9.11 with a support level at 9.10 and a resistance at 11.65, providing an opportunity for a 28 % return. Trading at a 36 % level between the 52week High (13.37) and 52 week Low (6.68). The average analyst 1-year target price is 20.0 with an average strong_buy and a score of 1.5.

TD Buy
28 %
MNOV
9.11
MediciNova, Inc.
HiLo
36.3 %
Support
9.10
Resistance
11.65
Target1Y
20.00
Rated
strong_buy
Score
1.5
52week high
13.37
52week low
6.68
50DMA
10.83
200DMA
10.00
10DMA
9.81
20DMA
10.79
100DMA
9.71
Volume
51198
AvgDayVol
121078
MarketCap
392287520
EBITDA
-15874278
Revenue
0
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#GoldenCross $G1A.DE at 26.67 R7  HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP  #DAX #Aktien #Boerse #stocks
Bull, Europe, Germany
13 views
Bull, Europe, Germany
13 views

#GoldenCross $G1A.DE at 26.67 R7 HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP #DAX #Aktien #Boerse #stocks

Andreas Aigner - 2019-09-19

Golden Cross detected for G1A.DE (GEA GROUP AG) at the close price of 26.67. Trading at a 54 % level…

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9  HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading
Bear, Europe, Financial Services
9 views
Bear, Europe, Financial Services
9 views

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9 HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading

Andreas Aigner - 2019-09-19

TD SELL detected for DLG.L (DIRECT LINE INSURANC) at the close price of 305.40 with a support level at 279.90…

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.